Christina Termini

17PUBLICATIONS
33CO-AUTHORS
Haematological tumoursApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Particle physicsGlycoconjugatesHaematology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (17)

|Feb 23, 2026
HS6ST1 regulates acute myeloid leukemia chemotherapy resistance via TGF-β1 signaling.

Christina Termini, Kelsey Woodruff, Diya Patel

|Feb 11, 2026
The bone marrow niche and hematopoietic system are distinctly remodeled by CD45-targeted astatine-211 radioimmunotherapy.

Matthew W Hagen, Nicollette J Setiawan, Shannon Dexter

|Nov 27, 2025
Blocking ferroptosis to expand human HSCs.

Isabella M Alves, Christina Marie Termini

|Nov 24, 2025
Depletion of microenvironmental syndecan-2 impairs hematopoietic stem cell self-renewal and cytokine responses.

Matthew W Hagen, Nicollette J Setiawan, Rachel Wellington

|Nov 24, 2025
Inhibition of farnesyltransferase activity diminishes hematopoietic stem cell <i>ex vivo</i> expansion ability.

Carli Newman, Isabella M Alves, Matthew W Hagen

|Oct 02, 2025
SLAM passes the haematopoietic stem cell identity test.

Christina Marie Termini

Pageof 3

Frequent Collaborators

6 joint publications

Matthew W Hagen

4 joint publications

Kelsey Woodruff

2 joint publications

Shannon L Dexter

2 joint publications

Carli Newman